Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Get the Deal
Claim MarketBeat All Access Sale Promotion
LON:HLN

Haleon 2/28/2025 Earnings Report

Haleon logo
GBX 343.80 +1.50 (+0.44%)
As of 05/22/2026 12:29 PM Eastern
ProfileEarnings HistoryForecast

Haleon EPS Results

Actual EPS
GBX 15.80
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Haleon Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Haleon Announcement Details

Quarter
Date
2/28/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Haleon Earnings Headlines

Haleon PLC (HLN) Gets a Buy from Goldman Sachs
May 7, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HLN/pressreleases/1640849/haleon-plc-hln-gets-a-buy-from-goldman-sachs/
Haleon Updates Share Capital and Voting Rights for Disclosure Purposes
May 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-updates-share-capital-and-voting-rights-for-disclosure-purposes?utm_source=marketbeat.com&utm_medium=referral
The Iran War Just Broke the Gold Market
The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged… Defense stocks exploded…And gold ripped past $5,000.tc pixel
May 23 at 1:00 AM  |  Behind the Markets (Ad)
9 Best IPO Stocks to Buy in 2026
April 30, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/9-best-ipo-stocks-to-buy-in-2026-1748569/
Haleon Shareholders Back All Resolutions at 2026 AGM, Endorsing Board and Capital Flexibility
April 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-shareholders-back-all-resolutions-at-2026-agm-endorsing-board-and-capital-flexibility?utm_source=marketbeat.com&utm_medium=referral
Haleon Cancels 8.7 Million Shares Under Ongoing Buyback Programme
April 20, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-cancels-8-7-million-shares-under-ongoing-buyback-programme?utm_source=marketbeat.com&utm_medium=referral
See More Haleon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Haleon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Haleon and other key companies, straight to your email.

About Haleon

Haleon (LON:HLN) (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

View Haleon Profile
Earnings Tools